What is Prime Medicine's current ratio?

Prime Medicine (PRME) reported current ratio of 3.8× in Q1 2026.

How has Prime Medicine's current ratio changed year-over-year?

Prime Medicine's current ratio decreased by 20.4% year-over-year, from 4.8× to 3.8×.

What is the long-term trend for Prime Medicine's current ratio?

Over 4 years (2021 to 2025), Prime Medicine's current ratio has grown at a 0.9% compound annual growth rate (CAGR), from 4.7× to 4.8×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Prime Medicine PRME Current ratio

Current ratio at other companies

Eli LillyLLY

1.5×+0.1×

Vertex PharmaceuticalsVRTX

3×+0.4×

Intellia TherapeuticsNTLA

6.1×+1.2×

CRISPR TherapeuticsCRSP

18×+2.3×

Beam TherapeuticsBEAM

17×+8.2×

RegenxbioRGNX

2.6×-0.3×

Other financials

Income statement

See full

Revenue$838.0K-61.6%

Operating income-$50.7M+3.3%

Net income-$49.1M+5.3%

EPS (diluted)-$0.28+30.0%

Balance sheet

See full

Cash & equivalents$77.8M-26.6%

Total debt$114.5M-5.5%

Total equity$76.7M-28.3%

Total assets$294.7M-10.2%

Cash flow

See full

Operating cash flow-$42.7M+12.6%

CapEx$214.0K-91.2%

Free cash flow-$42.9M+16.3%

Valuation

See full

Market cap$574.36M+111%

Enterprise value$611.08M+113%

P/S124×+6.3×

Profitability

See full

Operating margin-4,498.1%-1,134pp

Net margin-4,342.4%-1,099pp

FCF margin-3,607.4%—

Returns & leverage

See full

Return on equity-216.1%+1,519pp

Debt / equity1.5×+0.4×

Where this comes from

Calculated from Prime Medicine’s reported figures.

total current assets/total current liabilities=3.8×

Based on the most recent quarter.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prime Medicine's current ratio?: Prime Medicine (PRME) reported current ratio of 3.8× in Q1 2026.
How has Prime Medicine's current ratio changed year-over-year?: Prime Medicine's current ratio decreased by 20.4% year-over-year, from 4.8× to 3.8×.
What is the long-term trend for Prime Medicine's current ratio?: Over 4 years (2021 to 2025), Prime Medicine's current ratio has grown at a 0.9% compound annual growth rate (CAGR), from 4.7× to 4.8×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.